Top

Published in:

01-01-2011 | Review

Genetic Creutzfeldt–Jakob disease and fatal familial insomnia: insights into phenotypic variability and disease pathogenesis

Authors: Sabina Capellari, Rosaria Strammiello, Daniela Saverioni, Hans Kretzschmar, Piero Parchi

Published in: Acta Neuropathologica | Issue 1/2011

Abstract

Human prion diseases are a group of rare neurodegenerative disorders characterized by the conversion of the constitutively expressed prion protein, PrP^C, into an abnormally aggregated isoform, called PrP^Sc. While most people who develop a prion disease have no identifiable cause and a few acquire the disease through an identified source of infection, about 10–15% of patients are affected by a genetic form and carry either a point mutation or an insertion of octapeptide repeats in the prion protein gene. Prion diseases show the highest extent of phenotypic heterogeneity among neurodegenerative disorders and comprise three major disease entities with variable though overlapping phenotypic features: Creutzfeldt–Jakob disease (CJD), fatal insomnia and the Gerstmann–Sträussler–Scheinker syndrome. Both CJD and fatal insomnia are fully transmissible diseases, a feature that led to the isolation and characterization of different strains of the agent or prion showing distinctive clinical and neuropathological features after transmission to syngenic animals. Here, we review the current knowledge of the effects of the pathogenic mutations linked to genetic CJD and fatal familial insomnia on the prion protein metabolism and physicochemical properties, the disease phenotype and the strain characteristics. The data derived from studies in vitro and from those using cell and animal models are compared with those obtained from the analyses of the naturally occurring disease. The extent of phenotypic variation in genetic prion disease is analyzed in comparison to that of the sporadic disease, which has recently been the topic of a systematic and detailed characterization.

Antoine JC, Laplanche JL, Mosnier JF, Beaudry P, Chatelain J, Michel D (1996) Demyelinating peripheral neuropathy with Creutzfeldt–Jakob disease and mutation at codon 200 of the prion protein gene. Neurology 46:1123–1127PubMed

Apetri AC, Surewicz K, Surewicz WK (2004) The effect of disease-associated mutations on the folding pathway of human prion protein. J Biol Chem 279:18008–18014PubMedCrossRef

Apetri AC, Vanik DL, Surewicz WK (2005) Polymorphism at residue 129 modulates the conformational conversion of the D178N variant of human prion protein 90–231. Biochemistry 44:15880–15888PubMedCrossRef

Asante EA, Gowland I, Grimshaw A et al (2009) Absence of spontaneous disease and comparative prion susceptibility of transgenic mice expressing mutant human prion proteins. J Gen Virol 90:546–558PubMedCrossRef

Ashok A, Hegde RS (2009) Selective processing and metabolism of disease-causing mutant prion proteins. PLoS Pathog 5:e1000479PubMedCrossRef

Baldin E, Capellari S, Provini F et al (2009) A case of fatal familial insomnia in Africa. J Neurol 256:1778–1779PubMedCrossRef

Bamdad K, Naderi-Manesh H (2007) Contribution of a putative salt bridge and backbone dynamics in the structural instability of human prion protein upon R208H mutation. Biochem Biophys Res Commun 364:719–724PubMedCrossRef

Barducci A, Chelli R, Procacci P, Schettino V (2005) Misfolding pathways of the prion protein probed by molecular dynamics simulations. Biophys J 88:1334–1343PubMedCrossRef

Baron T, Bencsik A, Vulin J et al (2008) A C-terminal protease-resistant prion fragment distinguishes ovine “CH1641-like” scrapie from bovine classical and L-Type BSE in ovine transgenic mice. PLoS Pathog 4:e1000137PubMedCrossRef

10.

Barron RM, Thomson V, Jamieson E et al (2001) Changing a single amino acid in the N-terminus of murine PrP alters TSE incubation time across three species barriers. EMBO J 20:5070–5078PubMedCrossRef

11.

Basset-Leobon C, Uro-Coste E, Peoc’h K et al (2006) Familial Creutzfeldt–Jakob disease with an R208H–129V haplotype and kuru plaques. Arch Neurol 63:449–452PubMedCrossRef

12.

Beck JA, Mead S, Campbell TA et al (2001) Two-octapeptide repeat deletion of prion protein associated with rapidly progressive dementia. Neurology 57:354–356PubMed

13.

Bessen RA, Marsh RF (1994) Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. J Virol 68:7859–7868PubMed

14.

Bishop MT, Hart P, Aitchison L et al (2006) Predicting susceptibility and incubation time of human-to-human transmission of vCJD. Lancet Neurol 5:393–398PubMedCrossRef

15.

Bishop MT, Will RG, Manson JC (2010) Defining sporadic Creutzfeldt–Jakob disease strains and their transmission properties. Proc Natl Acad Sci USA 107:12005–12010PubMedCrossRef

16.

Brown P, Goldfarb LG, Gibbs CJ, Gajdusek DC (1991) The phenotypic expression of different mutations in transmissible familial Creutzfeldt–Jakob disease. Eur J Epidemiol 7:469–476PubMedCrossRef

17.

Brown P, Goldfarb LG, Kovanen J et al (1992) Phenotypic characteristics of familial Creutzfeldt–Jakob disease associated with the codon 178Asn PRNP mutation. Ann Neurol 31:282–285PubMedCrossRef

18.

Bruce ME (1993) Scrapie strain variation and mutation. Br Med Bull 49:822–838PubMed

19.

Bruce ME, Will RG, Ironside JW et al (1997) Transmissions to mice indicate that ‘new variant’ CJD is caused by the BSE agent. Nature 389:498–501PubMedCrossRef

20.

Calzolai L, Zahn R (2003) Influence of pH on NMR structure and stability of the human prion protein globular domain. J Biol Chem 278:35592–35596PubMedCrossRef

21.

Campana V, Sarnataro D, Fasano C, Casanova P, Paladino S, Zurzolo C (2006) Detergent-resistant membrane domains but not the proteasome are involved in the misfolding of a PrP mutant retained in the endoplasmic reticulum. J Cell Sci 119:433–442PubMedCrossRef

22.

Capellari S, Vital C, Parchi P et al (1997) Familial prion disease with a 144 bp insertion in the prion protein gene in a Basque family. Neurology 49:133–141PubMed

23.

Capellari S, Zaidi SI, Long AC, Kwon EE, Petersen RB (2000) The thr183ala mutation, not the loss of the first glycosylation site, alters the physical properties of the prion protein. J Alzheimers Dis 2:27–35PubMed

24.

Capellari S, Parchi P, Russo CM (2000) Effect of the E200K mutation on prion protein metabolism. Comparative study of a cell model and human brain. Am J Pathol 157:613–622PubMed

25.

Capellari S, Parchi P, Wolff BD et al (2002) Creutzfeldt–Jakob disease associated with a deletion of two repeats in the prion protein gene. Neurology 59:1628–1630PubMed

26.

Capellari S, Cardone F, Notari S et al (2005) Creutzfeldt–Jakob disease associated with the R208H mutation in the prion protein gene. Neurology 64:905–907PubMed

27.

Cardone F, Liu QG, Petraroli R et al (1999) Prion protein glycotype analysis in familial and sporadic Creutzfeldt–Jakob disease patients. Brain Res Bull 6:429–433CrossRef

28.

Caughey B, Race RE, Ernst D, Buchmeier MJ, Chesebro B (1989) Prion protein biosynthesis in scrapie-infected and uninfected neuroblastoma cells. J Virol 63:175–181PubMed

29.

Chapman J, Ben-Israel J, Goldhammer Y, Korczyn AD (1994) The risk of developing Creutzfeldt–Jakob disease in subjects with the PRNP gene codon 200 point mutation. Neurology 44:1683–1686PubMed

30.

Chasseigneaux S, Haïk S, Laffont-Proust I et al (2006) V180I mutation of the prion protein gene associated with atypical PrP^Sc glycosylation. Neurosci Lett 408:165–169PubMedCrossRef

31.

Chen SG, Parchi P, Brown P et al (1997) Allelic origin of the abnormal prion proteins in familial prion diseases. Nat Med 3:1009–1015PubMedCrossRef

32.

Chesebro B (2003) Introduction to the transmissible spongiform encephalopathies or prion diseases. Br Med Bull 66:1–20PubMedCrossRef

33.

Chiesa R, Piccardo P, Ghetti B, Harris DA (1998) Neurological illness in transgenic mice expressing a prion protein with an insertional mutation. Neuron 21:1339–1351PubMedCrossRef

34.

Chiesa R, Pestronk A, Schmidt RE et al (2001) Primary myopathy and accumulation of PrP^Sc-like molecules in peripheral tissues of transgenic mice expressing a prion protein insertional mutation. Neurobiol Dis 8:279–288PubMedCrossRef

35.

Chiti F, Dobson CM (2006) Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem 75:333–366PubMedCrossRef

36.

Choi CJ, Kanthasamy A, Anantharam V, Kanthasamy AG (2006) Interaction of metals with prion protein: possible role of divalent cations in the pathogenesis of prion diseases. Neurotoxicology 27:777–787PubMedCrossRef

37.

Clerici F, Elia A, Girotti F et al (2008) Atypical presentation of CJD: the first Italian case associated with E196K mutation in the PRNP gene. J Neurol Sci 275:145–147PubMedCrossRef

38.

Cochran EJ, Bennett DA, Cervenakova L et al (1996) Familial Creutzfeldt–Jakob disease with a five-repeat octapeptide insert mutation. Neurology 47:727–733PubMed

39.

Cohen FE, Pan KM, Huang Z, Baldwin M, Fletterick RJ, Prusiner SB (1994) Structural clues to prion replication. Science 264:530–531PubMedCrossRef

40.

Collins S, Boyd A, Fletcher A et al (2000) Novel prion protein gene mutation in an octogenarian with CJD. Arch Neurol 57:1058–1063PubMedCrossRef

41.

D’Alessandro M, Petraroli R, Ladogana A, Pocchiari M (1998) High incidence of Creutzfeldt–Jakob disease in rural Calabria, Italy. Lancet 352:1989–1990PubMedCrossRef

42.

Dossena S, Imeri L, Mangieri M et al (2008) Mutant prion protein expression causes motor and memory deficits and abnormal sleep patterns in a transgenic mouse model. Neuron 60:598–609PubMedCrossRef

43.

Drisaldi B, Stewart RS, Adles C et al (2003) Mutant PrP is delayed in its exit from the endoplasmic reticulum, but neither wild-type nor mutant PrP undergoes retrotranslocation prior to proteasomal degradation. J Biol Chem 278:21732–21743PubMedCrossRef

44.

Endo T, Groth D, Prusiner SB, Kobata A (1989) Diversity of oligosaccharide structures linked to asparagines of the scrapie prion protein. Biochemistry 28:8380–8388PubMedCrossRef

45.

Gabizon R, Rosenmann H, Meiner Z et al (1993) Mutation and polymorphism of the prion protein gene in Libyan Jews with Creutzfeldt–Jakob disease. Am J Hum Genet 53:828–835PubMed

46.

Gabizon R, Telling G, Meiner Z, Halimi M, Kahana I, Prusiner SB (1996) Insoluble wild-type and protease-resistant mutant prion protein in brains of patients with inherited prion diseases. Nat Med 2:59–64PubMedCrossRef

47.

Gambetti P, Parchi P, Petersen RB, Chen SG, Lugaresi E (1995) Fatal familial insomnia and familial Creutzfeldt–Jakob disease: clinical, pathological and molecular features. Brain Pathol 5:43–51PubMedCrossRef

48.

Garcin R, Brion S, Khochneviss AA (1963) Le syndrome de Creutzfeldt–Jakob et les syndromes corticotries du presenium (a l’occasion de observations anatomo-cliniques). Rev Neurol (Paris) 109:419–441

49.

Gelpi E, Kovacs GG, Ströbel T et al (2005) Prion disease with a 144 base pair insertion: unusual cerebellar prion protein immunoreactivity. Acta Neuropathol 110:513–519PubMedCrossRef

50.

Goldfarb LG, Mitrová E, Brown P, Toh BK, Gajdusek DC (1990) Mutation in codon 200 of scrapie amyloid protein gene in two clusters of Creutzfeldt–Jakob disease in Slovakia. Lancet 336:514–515PubMedCrossRef

51.

Goldfarb LG, Brown P, McCombie WR et al (1991) Transmissible familial Creutzfeldt–Jakob disease associated with five, seven and eight extra octapeptide coding repeats in the PRNP gene. Proc Natl Acad Sci USA 88:10926–10930PubMedCrossRef

52.

Goldfarb LG, Brown P, Little BW et al (1993) A new (two-repeat) octapeptide coding insert mutation in Creutzfeldt–Jakob disease. Neurology 43:2392–2394PubMed

53.

Goldfarb LG, Petersen RB, Tabaton M et al (1992) Fatal familial insomnia and familial Creutzfeldt Jakob disease: disease phenotype determined by a DNA polymorphism. Science 258:806–808PubMedCrossRef

54.

Goldgaber D, Goldfarb LG, Brown P et al (1989) Mutations in familial Creutzfeldt–Jakob disease and Gerstmann-Sträussler-Scheinker’s syndrome. Exp Neurol 106:204–206PubMedCrossRef

55.

Grasbon-Frodl E, Lorenz H, Mann U, Nitsch RM, Windl O, Kretzschmar HA (2004) Loss of glycosylation associated with the T183A mutation in human prion disease. Acta Neuropathol 108:476–484PubMedCrossRef

56.

Hama T, Iwasaki Y, Niwa H et al (2009) An autopsied case of panencephalopathic-type Creutzfeldt–Jakob disease with mutation in the prion protein gene at codon 232 and type 1 prion protein. Neuropathology 296:727–734CrossRef

57.

Hainfellner JA, Parchi P, Kitamoto T, Jarius C, Gambetti P, Budka H (1999) A novel phenotype in familial Creutzfeldt–Jakob disease: prion protein gene E200K mutation coupled with valine at codon 129 and type 2 protease-resistant prion protein. Ann Neurol 45:812–816PubMedCrossRef

58.

Hill AF, Joiner S, Beck JA et al (2006) Distinct glycoform ratios of protease resistant prion protein associated with PRNP point mutations. Brain 129:676–685PubMedCrossRef

59.

Hsiao KK, Scott M, Foster D, Groth DF, DeArmond SJ, Prusiner SB (1990) Spontaneous neurodegeneration in transgenic mice with mutant prion protein. Science 250:1587–1590PubMedCrossRef

60.

Hsiao KK, Groth D, Scott M et al (1994) Serial transmission in rodents of neurodegeneration from transgenic mice expressing mutant prion protein. Proc Natl Acad Sci USA 91:9126–9130PubMedCrossRef

61.

Huang Z, Gabriel JM, Baldwin MA, Fletterick RJ, Prusiner SB, Cohen FE (1994) Proposed three-dimensional structure for the cellular prion protein. Proc Natl Acad Sci USA 91:7139–7143PubMedCrossRef

62.

Ivanova L, Barmada S, Kummer T, Harris DA (2001) Mutant prion proteins are partially retained in the endoplasmic reticulum. J Biol Chem 276:42409–42421PubMedCrossRef

63.

Jackson WS, Borkowski AW, Faas H et al (2009) Spontaneous generation of prion infectivity in fatal familial insomnia knocking mice. Neuron 63:438–450PubMedCrossRef

64.

Jacob H, Pyrkosch W, Strube H (1950) The hereditary form of Creutzfeldt–Jakob disease (the Backer family). Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr 184:653–674PubMed

65.

Jansen C, van Swieten JC, Capellari S et al (2009) Inherited Creutzfeldt–Jakob disease in a Dutch patient with a novel five octapeptide repeat insertion and unusual cerebellar morphology. J Neurol Neurosurg Psychiatry 80:1386–1389PubMedCrossRef

66.

Jarius C, Kovacs GG, Belay G, Hainfellner JA, Mitrova E, Budka H (2003) Distinctive cerebellar immunoreactivity for the prion protein in familial (E200K) Creutzfeldt–Jakob disease. Acta Neuropathol 105:49–54

67.

Jin K, Shiga Y, Shibuya S et al (2004) Clinical features of Creutzfeldt–Jakob disease with V180I mutation. Neurology 62:502–505PubMed

68.

Kahana E, Zilber N, Abraham M (1991) Do Creutzfeldt–Jakob disease patients of Jewish Libyan origin have unique clinical features? Neurology 41:1390–1392PubMed

69.

Kalastavadi T, True HL (2008) Prion protein insertional mutations increase aggregation propensity but not fiber stability. BMC Biochem 9:7PubMedCrossRef

70.

Kascsak RJ, Rubenstein R, Merz PA et al (1986) Immunological comparison of scrapie-associated fibrils isolated from animals infected with four different scrapie strains. J Virol 59:676–683PubMed

71.

Kiachopoulos S, Bracher A, Winklhofer KF, Tatzelt J (2005) Pathogenic mutations located in the hydrophobic core of the prion protein interfere with folding and attachment of the glycosylphosphatidylinositol anchor. J Biol Chem 280:9320–9329PubMedCrossRef

72.

Kirschbaum WR (1924) Zwei eigenartige Erkrankung des Zentralnervensystems nach Art der spatischen Pseudosklerose (Jakob). Z Neurol Pyschiatry 92:175–220CrossRef

73.

Kobayashi A, Sakuma N, Matsuura Y, Mohri S, Aguzzi A, Kitamoto T (2010) Experimental verification of a traceback phenomenon in prion infection. J Virol 84:3230–3238PubMedCrossRef

74.

Kong Q, Surewicz WK, Petersen RB et al (2003) Inherited prion diseases. In: Prusiner SB (ed) Prion biology disease. Cold Spring Harbor Laboratory Press, New York, pp 673–775

75.

Kovács GG, Trabattoni G, Hainfellner JA, Ironside JW, Knight RS, Budka H (2002) Mutations of the prion protein gene phenotypic spectrum. J Neurol 249:1567–1582PubMedCrossRef

76.

Kovács GG, Puopolo M, Ladogana A et al (2005) Genetic prion disease: the EUROCJD experience. Hum Genet 118:166–174PubMedCrossRef

77.

Krasnianski A, Bartl M, Sanchez Juan PJ et al (2008) Fatal familial insomnia: clinical features and early identification. Ann Neurol 63:658–661PubMedCrossRef

78.

Krebs B, Lederer RM, Windl O, Grasbon-Frodl EM, Zerr I, Kretzschmar HA (2005) Creutzfeldt–Jakob disease associated with an R148H mutation of the prion protein gene. Neurogenetics 6:97–100PubMedCrossRef

79.

Kretzschmar HA, Stowring LE, Westaway D, Stubblebine WH, Prusiner SB, Dearmond SJ (1986) Molecular cloning of a human prion protein cDNA. DNA 5:315–324PubMed

80.

Kretzschmar HA, Neumann M, Stavrou D (1995) Codon 178 mutation of the human prion protein gene in a German family (Backer family): sequencing data from 72-year old celloidin-embedded brain tissue. Acta Neuropathol 89:96–98PubMedCrossRef

81.

Ladogana A, Almonti S, Petraroli R et al (2001) Mutation of the PRNP gene at codon 211 in familial Creutzfeldt–Jakob disease. Am J Med Genet 103:133–137PubMedCrossRef

82.

Ladogana A, Puopolo M, Poleggi A et al (2005) High incidence of genetic human transmissible spongiform encephalopathies in Italy. Neurology 64:1592–1597PubMedCrossRef

83.

Langella E, Improta R, Crescenzi O, Barone V (2006) Assessing the acid-base and conformational properties of histidine residues in human prion protein (125–228) by means of pK(a) calculations and molecular dynamics simulations. Proteins 64:167–177PubMedCrossRef

84.

Laplanche JL, Delasnerie-Laupretre N, Brandel JP et al (1994) Molecular genetics of prion diseases in France. Neurology 44:2347–2351PubMed

85.

Lehmann S, Harris DA (1996) Mutant and infectious prion proteins display common biochemical properties in cultured cells. J Biol Chem 271:1633–1637PubMedCrossRef

86.

Lehmann S, Harris DA (1996) Two mutant prion proteins expressed in cultured cells acquire biochemical properties reminiscent of the scrapie isoform. Proc Natl Acad Sci 93:5610–5614PubMedCrossRef

87.

Leliveld SR, Stitz L, Korth C (2008) Expansion of the octarepeat domain alters the misfolding pathway but not the folding pathway of the prion protein. Biochemistry 47:6267–6278PubMedCrossRef

88.

Lewis PA, Tattum MH, Jones S et al (2006) Codon 129 polymorphism of the human prion protein influences the kinetics of amyloid formation. J Gen Virol 87:2443–2449PubMedCrossRef

89.

Liemann S, Glockshuber R (1999) Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein. Biochemistry 38:3258–3267PubMedCrossRef

90.

Little BW, Brown PW, Rodgers-Johnson P, Perl DP, Gajdusek DC (1986) Familial myoclonic dementia masquerading as Creutzfeldt–Jakob disease. Ann Neurol 20:231–239PubMedCrossRef

91.

Liu Z, Jia L, Piao Y et al. (2009) Creutzfeldt–Jakob disease with PRNP G114V mutation in a Chinese family. Acta Neurol Scand (epub ahead of print)

92.

Lorenz H, Windl O, Kretzschmar HA (2002) Cellular phenotyping of secretory and nuclear prion proteins associated with inherited prion diseases. J Biol Chem 277:8508–8516PubMedCrossRef

93.

Lugaresi E, Medori R, Montagna P et al (1986) Fatal familial insomnia and dysautonomia with selective degeneration of thalamic nuclei. N Engl J Med 315:997–1003PubMedCrossRef

94.

Ma J, Lindquist S (2001) Wild-type PrP and a mutant associated with prion disease are subject to retrograde transport and proteasome degradation. Proc Natl Acad Sci 98:14955–14960PubMedCrossRef

95.

Manetto V, Medori R, Cortelli P et al (1992) Fatal familial insomnia: clinical and pathologic study of five new cases. Neurology 42:312–319PubMed

96.

Manson JC, Jamieson E, Baybutt H et al (1999) A single amino acid alteration (101L) introduced into murine PrP dramatically alters incubation time of transmissible spongiform encephalopathy. EMBO J 18:6855–6864PubMedCrossRef

97.

Martin JJ, Yap M, Nei IP, Tan TE (1983) Selective thalamic degeneration: report of a case with memory and mental disturbances. Clin Neuropathol 2:156–162PubMed

98.

Massignan T, Biasini E, Lauranzano E et al (2010) Mutant prion protein expression is associated with an alteration of the Rab GDP dissociation inhibitor alpha (GDI)/Rab11 pathway. Mol Cell Proteomics 9:611–622PubMedCrossRef

99.

Mastrianni JA, Iannicola C, Myers RM, DeArmond S, Prusiner SB (1996) Mutation of the prion protein gene at codon 208 in familial Creutzfeldt–Jakob disease. Neurology 47:1305–1312PubMed

100.

Mastrianni J, Nixon R, Layzer R et al (1999) Prion protein conformation in a patient with sporadic fatal insomnia. N Engl J Med 340:1630–1638PubMedCrossRef

101.

Mastrianni JA, Capellari S, Telling GC et al (2001) Inherited prion disease caused by the V210I mutation: transmission to transgenic mice. Neurology 57:2198–2205PubMed

102.

Mead S, Poulter M, Beck J et al (2006) Inherited prion disease with six octapeptide repeat insertional mutation-molecular analysis of phenotypic heterogeneity. Brain 129:2297–2317PubMedCrossRef

103.

Mead S, Webb TEF, Campbell TA et al (2007) Inherited prion disease with 5-OPRI. Neurology 69:730–738PubMedCrossRef

104.

Medori R, Tritschler HJ, LeBlanc A et al (1992) Fatal familial insomnia is a prion disease with a mutation at codon 178 of the prion gene. N Engl J Med 326:444–449PubMedCrossRef

105.

Meggendorfer F (1930) Klinische und genealogische Beobachtungen bein einem Fall von spastischen Pseudokosklerose Jakobs. Z Neurol Psychiatry 128:337–341CrossRef

106.

Mitrova E, Belay G (2002) Creutzfeldt–Jakob disease with E200K mutation in Slovakia: characterization and development. Acta Virol 46:31–39PubMed

107.

Miyakawa T, Inoue K, Iseki E et al (1998) Japanese Creutzfeldt–Jakob disease patients exhibiting high incidence of the E200K PRNP mutation and located in the basin of a river. Neurol Res 20:684–688PubMed

108.

Monari L, Chen SC, Brown P et al (1994) Fatal familial insomnia and familial Creutzfeldt–Jakob disease: different prion proteins determined by a DNA polymorphism. Proc Natl Acad Sci USA 91:2839–2842PubMedCrossRef

109.

Montagna P, Gambetti P, Cortelli P, Lugaresi E (2003) Familial and sporadic fatal insomnia. Lancet Neurol 2:167–176PubMedCrossRef

110.

Neufeld MY, Josiphov J, Korczyn AD (1992) Demyelinating peripheral neuropathy in Creutzfeldt–Jakob disease. Muscle Nerve 15:1234–1239PubMedCrossRef

111.

Nicolas O, Gavín R, del Río JA (2009) New insights into cellular prion protein (PrPc) functions: the “ying and yang” of a relevant protein. Brain Res Rev 61:170–184PubMedCrossRef

112.

Nitrini R, Rosemberg S, Passos-Bueno MR et al (1997) Familial spongiform encephalopathy with distinct clinico-pathological features associated with a novel prion gene mutation at codon 183. Ann Neurol 42:138–146PubMedCrossRef

113.

Nonno R, Di Bari M, Cardone F et al (2006) Efficient transmission and characterization of Creutzfeldt–Jakob disease strains in bank voles. PLoS Pathog 2:e12PubMedCrossRef

114.

Notari S, Capellari S, Giese A et al (2004) Effects of different experimental conditions on the PrPSc core generated by protease digestion: implications for strain typing and molecular classification of CJD. J Biol Chem 279:16797–16804PubMedCrossRef

115.

Notari S, Strammiello R, Capellari S et al (2008) Characterization of truncated forms of abnormal prion protein in Creutzfeldt–Jakob disease. J Biol Chem 283:30557–30565PubMedCrossRef

116.

Oda M (1976) Thalamus degeneration in Japan: a review from clinical and pathological veiwpoints. Appl Neurophysiol 39:178–198PubMed

117.

Owen F, Poulter M, Lofthouse R et al (1989) Insertion in prion protein gene in familial Creutzfeldt–Jakob disease. Lancet 7:51–52CrossRef

118.

Palmer MS, Dryden AJ, Hughes JT, Collinge J (1991) Homozygous prion protein genotype predisposes to sporadic Creutzfeldt–Jakob disease. Nature 352:340–342PubMedCrossRef

119.

Parchi P, Castellani R, Cortelli P et al (1995) Regional distribution of protease-resistant prion protein in fatal familial insomnia. Ann Neurol 38:21–29PubMedCrossRef

120.

Parchi P, Castellani R, Capellari S et al (1996) Molecular basis of phenotypic variability in sporadic Creutzfeldt–Jakob disease. Ann Neurol 39:767–778PubMedCrossRef

121.

Parchi P, Capellari S, Chen SG et al (1997) Typing prion isoforms. Nature 386:232–234PubMedCrossRef

122.

Parchi P, Petersen RB, Chen SG et al (1998) Molecular pathology of fatal familial insomnia. Brain Pathol 8:539–548PubMedCrossRef

123.

Parchi P, Giese A, Capellari S et al (1999) Classification of sporadic Creutzfeldt–Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 46:224–233PubMedCrossRef

124.

Parchi P, Capellari S, Chin S et al (1999) A sporadic prion disease mimicking fatal familial insomnia. Neurology 52:1757–1763PubMed

125.

Parchi P, Zou W, Wang W et al (2000) Genetic influence on the structural variations of the abnormal prion protein. Proc Natl Acad Sci USA 97:10168–10171PubMedCrossRef

126.

Parchi P, Strammiello R, Notari S et al (2009) Incidence and spectrum of sporadic Creutzfeldt–Jakob disease variants with mixed phenotype and co-occurrence of PrP^Sc types: an updated classification. Acta Neuropathol 118:659–671PubMedCrossRef

127.

Parchi P, Notari S, Weber P et al (2009) Inter-laboratory assessment of PrP^Sc typing in Creutzfeldt–Jakob disease: a western blot study within the NeuroPrion Consortium. Brain Pathol 19:384–391PubMedCrossRef

128.

Parchi P, Cescatti M, Notari S et al. (2010) Agent strain variation in human prion disease: insights from a molecular and pathological revision of the NIH series of experimentally transmitted disease. Brain 133:3030–3042

129.

Pastore M, Chin SS, Bell KL et al (2005) Creutzfeldt–Jakob disease (CJD) with a mutation at codon 148 of prion protein gene: relationship with sporadic CJD. Am J Pathol 167:1729–1738PubMed

130.

Peoc’h K, Manivet P, Beaudry P et al (2000) Identification of three novel mutations (E196K, V203I, E211Q) in the prion protein gene (PRNP) in inherited prion diseases with Creutzfeldt–Jakob disease phenotype. Hum Mutat 5:482CrossRef

131.

Petersen RB, Tabaton M, Berg L et al (1992) Analysis of the prion gene in thalamic dementia. Neurology 42:1859–1863PubMed

132.

Petersen RB, Parchi P, Richardson SL, Urig CB, Gambetti P (1996) Effect of the D178N mutation and the codon 129 polymorphism on the metabolism of the prion protein. J Biol Chem 271:12661–12668PubMedCrossRef

133.

Pocchiari M, Salvatore M, Cutruzzola F et al (1993) A new point mutation of the prion protein gene in Creutzfeldt–Jakob disease. Ann Neurol 34:802–807PubMedCrossRef

134.

Priola SA, Chesebro B (1998) Abnormal properties of prion protein with insertional mutations in different cell types. J Biol Chem 273:11980–11985PubMedCrossRef

135.

Prusiner SB (1998) Prions. Proc Natl Acad Sci USA 95:13363–13383PubMedCrossRef

136.

Puckett C, Concannon P, Casey C, Hood L (1991) Genomic structure of human prion protein gene. Am J Genet 49:320–329

137.

Puoti G, Rossi G, Giaccone G et al (2000) Polymorphism at codon 129 of PRNP affects the phenotypic expression of Creutzfeldt–Jakob disease linked to the E200K mutation. Ann Neurol 48:269–270PubMedCrossRef

138.

Riek R, Wider G, Billeter M, Hornemann S, Glockshuber R, Wüthrich K (1998) Prion protein NMR structure and familial human spongiform encephalopathies. Proc Natl Acad Sci 95:11667–11672PubMedCrossRef

139.

Ripoll L, Laplanche JL, Salzmann M et al (1993) A new point mutation in the prion protein gene at codon 210 in Creutzfeldt–Jakob disease. Neurology 43:1934–1938PubMed

140.

Rodriguez MM, Peoc’h K, Haïk S et al (2005) A novel mutation (G114V) in the prion protein gene in a family with inherited prion disease. Neurology 64:1455–1457PubMed

141.

Rodríguez-Martínez AB, Barreau C, Coupry I et al (2005) Ancestral origins of the prion protein gene D178N mutation in the Basque Country. Hum Genet 117:61–69PubMedCrossRef

142.

Roeber S, Krebs B, Neumann M et al (2005) Creutzfeldt–Jakob disease in a patient with an R208H mutation of the prion protein gene (PRNP) and a 17-kDa prion protein fragment. Acta Neuropathol 109:443–448PubMedCrossRef

143.

Roeber S, Grasbon-Frodl EM, Windl O et al (2008) Evidence for a pathogenic role of different mutations at codon 188 of PRNP. PLoS One 3:e2147PubMedCrossRef

144.

Rogers M, Taraboulos A, Scott M, Groth D, Prusiner SB (1990) Intracellular accumulation of the cellular prion protein after mutagenesis of its Asn-linked glycosylation sites. Glycobiology 1:101–109PubMedCrossRef

145.

Roos R, Gajdusek DC, Gibbs CJ (1973) The clinical characteristics of transmissible Creutzfeldt–Jacob disease. Brain 96:1–20PubMedCrossRef

146.

Rosenmann H, Talmor G, Halimi M, Yanai A, Gabizon R, Meiner Z (2001) Prion protein with an E200K mutation displays properties similar to those of the cellular isoform PrP(C). J Neurochem 76:1654–1662PubMedCrossRef

147.

Schiff E, Campana V, Tivodar S, Lebreton S, Gousset K, Zurzolo C (2008) Coexpression of wild-type and mutant prion proteins alters their cellular localization and partitioning into detergent-resistant membranes. Traffic 9:1101–1115PubMedCrossRef

148.

Schulman S (1957) Bilateral symmetrical degeneration of the thalamus: a clinico-pathological study. J Neuropathol Exp Neurol 16:446–470PubMedCrossRef

149.

Shimizu H, Yamada M, Matsubara N et al (2009) Creutzfeldt–Jakob disease with an M232R substitution: report of a patient showing slowly progressive disease with abundant plaque-like PrP deposits in the cerebellum. Neuropathology 29:735–743PubMedCrossRef

150.

Skworc KH, Windl O, Schulz-Schaeffer WJ et al (1999) Familial Creutzfeldt–Jakob disease with a novel 120-bp insertion in the prion protein gene. Ann Neurol 46:693–700CrossRef

151.

Silvestrini MC, Cardone F, Maras B et al (1997) Identification of the prion protein allotypes which accumulate in the brain of sporadic and familial Creutzfeldt–Jakob disease patients. Nat Med 3:521–525PubMedCrossRef

152.

Soldevila M, Calafell F, Andrés AM et al (2003) Prion susceptibility and protective alleles exhibit marked geographic differences. Hum Mutat 22:104–105PubMedCrossRef

153.

Stahl N, Baldwin MA, Burlingame AL, Prusiner SB (1990) Identification of glycoinositol phospholipid linked and truncated forms of the scrapie prion protein. Biochemistry 29:8879–8884PubMedCrossRef

154.

Stern K (1939) Severe dementia associated with bilateral symmetrical degeneration of the thalamus. Brain 62:157–171CrossRef

155.

Swietnicki W, Petersen SB, Gambetti P, Surewicz WK (1998) Familial mutations and the thermodynamic stability of the recombinant human prion protein. J Biol Chem 273:31048–31052PubMedCrossRef

156.

Tateishi J, Brown P, Kitamoto T et al (1995) First experimental transmission of fatal familial insomnia. Nature 376:434–435PubMedCrossRef

157.

Telling GC, Parchi P, DeArmond SJ et al (1996) Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science 274:2079–2082PubMedCrossRef

158.

Vetrugno V, Malchow M, Liu Q, Marziali G, Battistini A, Pocchiari M (1999) Expression of wild-type and V210I mutant prion protein in human neuroblastoma cells. Neurosci Lett 270:41–44PubMedCrossRef

159.

Watanabe Y, Hiraoka W, Shimoyama Y, Horiuchi M, Kuwabara M, Inanami O (2008) Instability of familial spongiform encephalopathy-related prion mutants. Biochem Biophys Res Commun 366:244–249PubMedCrossRef

160.

Weissmann C, Flechsig E (2003) PrP knock-out and PrP transgenic mice in prion research. Br Med Bull 66:43–60PubMedCrossRef

161.

Windl O, Dempster M, Estibeiro JP et al (1996) Genetic basis of Creutzfeldt–Jakob disease in the United Kingdom: a systematic analysis of predisposing mutations and allelic variation in the PRNP gene. Hum Genet 98:259–264PubMedCrossRef

162.

Ye J, Han J, Shi Q et al (2008) Human prion disease with a G114V mutation and epidemiological studies in a Chinese family: a case series. J Med Case Reports 2:331PubMedCrossRef

163.

Yoshida H, Terada S, Ishizu H et al (2010) An autopsy case of Creutzfeldt–Jakob disease with a V180I mutation of the PrP gene and Alzheimer-type pathology. Neuropathology 30:159–164PubMedCrossRef

164.

Zahn R, Liu A, Luhrs T, Riek R et al (2000) NMR solution structure of the human prion protein. Proc Natl Acad Sci USA 97:145–150PubMedCrossRef

165.

Zhang Y, Swietnicki W, Zagorski MG, Surewicz WK, Sonnichsen FD (2000) Solution structure of the E200K variant of human prion protein. J Biol Chem 275:33650–33654PubMedCrossRef

166.

Zou WQ, Capellari S, Parchi P, Sy MS, Gambetti P, Chen SG (2003) Identification of novel proteinase K-resistant C-terminal fragments of PrP in Creutzfeldt–Jakob disease. J Biol Chem 278:40429–40436PubMedCrossRef

167.

Zuegg J, Gready JE (1999) Molecular dynamics simulations of human prion protein: importance of correct treatment of electrostatic interactions. Biochemistry 38:13862–13876PubMedCrossRef

Title: Genetic Creutzfeldt–Jakob disease and fatal familial insomnia: insights into phenotypic variability and disease pathogenesis
Authors: Sabina Capellari
Rosaria Strammiello
Daniela Saverioni
Hans Kretzschmar
Piero Parchi
Publication date: 01-01-2011
Publisher: Springer-Verlag
Published in: Acta Neuropathologica / Issue 1/2011
Print ISSN: 0001-6322
Electronic ISSN: 1432-0533
DOI: https://doi.org/10.1007/s00401-010-0760-4

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Genetic Creutzfeldt–Jakob disease and fatal familial insomnia: insights into phenotypic variability and disease pathogenesis

Abstract

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2011

Cellular and sub-cellular pathology of animal prion diseases: relationship between morphological changes, accumulation of abnormal prion protein and clinical disease

Diversity of prion diseases: (no) strains attached?

A novel seven-octapeptide repeat insertion in the prion protein gene (PRNP) in a Dutch pedigree with Gerstmann–Sträussler–Scheinker disease phenotype: comparison with similar cases from the literature

Genetic Creutzfeldt-Jakob disease associated with the E200K mutation: characterization of a complex proteinopathy

Molecular pathology of human prion disease

Tau, prions and Aβ: the triad of neurodegeneration